Australia's Control Bionics sees best session in 4 months on Numotion deal
07/04/2021 03:08
** Shares of Control Bionics Ltd CBL.AX , a
speech-generating devices maker, jump as much as 25% to A$75 –
their biggest intraday percentage gain since Dec 7, 2020
** Co enters reseller agreement with Numotion, a provider of
complex rehab technology, to resell Control Bionics products in
New Hampshire, Vermont, and New York urn:newsml:reuters.com:*:nASXZ6fGD
** Stock hits its highest level since March 2
** About 122,000 shares change hands, compared with the
30-day average volume of about 107,000 shares
(Reporting by Aditya Munjuluru in Bengaluru)
((aditya.srivastsav@thomsonreuters.com))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device